The role of remote gut inflammation in duodenojejunal dysmotility.
The aim of this prospective study was to determine the role of remote inflammation of the gut on duodenojejunal motor status by comparing patients with acute cholecystitis (AC) to those with biliary colic (BC). Thirty-six gallstone patients (11 AC and 25 BC) were explored. Manometric recordings were performed during fasting and after a 750-kcal meal and ended by an intravenous injection of 100 mg trimebutine. Patient data were compared to those of 20 healthy controls. Phases III were more frequently absent in AC patients than in BC patients (P < 0.01) and controls (P < 0.05). When phase III characteristics were similar between the AC and BC group, the phase III amplitude was lower in both groups than in controls (P < 0.0001). After the meal, the mean motor index in the jejunum expressed by the area under the curve (AUC) per 30-min period was higher in the AC group than in BC group and controls (P < 0.05). Specific motor phenomena were observed after the meal. In particular, propagating clusters of contractions (PCCs) were more frequent in AC patients than in BC (P < 0.05) and controls (P < 0.01). A lack of the expected decrease in the AUC during recording occurred with the same frequency in the AC and BC groups but was more frequent in patients than in controls (P < 0.05). In 8/11 patients in the AC group with duodenojejunal tracings before and 3 months after surgery, preoperative motor disturbances disappeared in 5/8 patients and improved in 3/8 patients. The higher frequency of duodenojejunal motor disturbances especially after a meal in patients with AC and their disappearance in most of the patients after removal of the infected gallbladder suggest that remote inflammation of the gut affects duodenojejunal motility.
Le Blanc-Louvry
I
I
Digestive Tract Research Group EA 3234/IFRMP 23, Rouen University Hospital, Rouen, France. philippe.ducrotte@chu-rouen.fr
Denis
P
P
Ducrotte
P
P
D000208:Acute Disease; D019540:Area Under Curve; D016009:Chi-Square Distribution; D002764:Cholecystitis / Q000473:pathology* / Q000503:physiopathology; D002769:Cholelithiasis / Q000473:pathology* / Q000503:physiopathology; D003085:Colic / Q000473:pathology* / Q000503:physiopathology; D004386:Duodenum / Q000503:physiopathology*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007583:Jejunum / Q000503:physiopathology*; D008297:Male; D008365:Manometry; D008875:Middle Aged; D011446:Prospective Studies; D018709:Statistics, Nonparametric; D014287:Trimebutine / Q000008:administration & dosage
D005765:Gastrointestinal Agents; D014287:Trimebutine